Yasemi̇n Kemal - Publications, H-index & Citations

Yasemi̇n Kemal

department of medical oncology

11H指数

56论文数

530被引数

收录论文 7

发表时间

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group 三阴性乳腺癌患者辅助内分泌治疗对无病生存期的影响：土耳其肿瘤学组的回顾性多中心队列研究

BMC Cancer

IF3.4

2026-08-03

OAAI

Mustafa Seyyar; Pervin Can Şancı; Akif Doğan; Sedat Biter; Tolga Köşeci; Onur Yazdan Balçık; Sinem Solmaz Karabel; Ali Kalem; Cengiz Akosman; Kezban Nur Pilancı; İlknur Deliktaş Onur; Ülkü Yalçıntaş Arslan; Yasemin Kemal; Tugay Avcı; Mustafa Şahbazlar; Seval Akay; Emir Gökhan Kahraman; Ayberk Bayramgil; Yunus Emre Altıntaş; Salih Tünbekici; Erdem Göker; Canan Çolak; Teyfik Demir; Güzin Demirağ; Gökçe Gül Güneysu; Musa Barış Aykan; İsmail Nazlı; Onur Alkan; İlker Nihat Ökten; Rumeysa Çolak; Mesut Yılmaz; Hasibe Bilge Gür; İlhan Hacıbekiroğlu; Müge Sönmez; Neslihan Özyurt; Okan Aydın; Kayhan Ertürk; Elif Şahin; Anıl Karakayalı; Ece Baydar; İlkay Çıtakkul; Gamze Emin; Atila Yıldırım; Ahmet Gülmez; Uğur Özberk; Efnan Algın; Çağlar Köseoğlu; Fatma Keskin Uzundere; Zuhat Urakçı; Melih Akpunar; Ali Alkan; Ali Süner; Pınar Peker; Yasemin Aydınalp Camadan; Lamia Şeker Can; Tuğba Akın Telli; Nargiz Majidova; Mehmet Uzun; Merve Kuday Özkan; Meltem Baykara; Halil Göksel Güzel; Hasan Çağrı Yıldırım; Umut Kefeli; Devrim Çabuk; Tulay Kus

Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study 早期三阴性乳腺癌中，新辅助培美曲塞与病理完全缓解及生存期的真实世界关联性：一项土耳其肿瘤学小组研究

Scientific Reports

IF3.9

2026-04-03

OAAI

Harun Muğlu; Erdem Sünger; Oğuzcan Özkan; Taha Koray Şahin; Bahadır Köylü; Kaan Helvacı; Yasemin Kemal; Umut Demirci; Fatih Selçukbiricik; Gül Başaran; Başak Oyan Uluç; Ömer Fatih Ölmez; Sercan Aksoy; Erhan Gökmen; Ahmet Bilici

Comparison of Six Cycles with Four Cycles of Chemotherapy and Atezolizumab in the First-Line Treatment of ES-SCLC; A Retrospective Multicenter Analysis 比较化疗六周期与四周期联合阿特珠单抗在ES-SCLC一线治疗中的效果；一项回顾性多中心分析

The Oncologist

IF0

2026-03-16

OAAI

Halil Göksel Güzel; Derya Kıvrak Salim; Saadettin Kılıçkap; Yasemin Kemal; Cengiz Akosman; Çağlar Köseoğlu; Alper Coşkun; Seval Orman; Safa Can Efil; Onur Baş; Esra Zeynelgil; Halil Çelik; Aytaç Terzi; Tuba Karaçelik; Nuri Karadurmuş; Erdem Çubukçu; Tuğba Başoğlu Tüylü; Burak Bilgin; Mustafa Erman; Serdar Karakaya; Kadir Eser; Elif Atağ; Melek Karakurt Eryılmaz; Banu Öztürk

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study 曲妥珠单抗德鲁替康在HER2+转移性乳腺癌患者中的真实世界疗效：土耳其肿瘤学组多中心研究

Therapeutic Advances in Medical Oncology

IF4.2

2026-03-13

PREAI

Taha Koray Sahin; Fatih Kemik; Harun Muglu; Bedriye Acikgöz Yildiz; Sedat Biter; Salih Tunbekici; Ahmet Oruc; Ali Kaan Guren; Kerim Kaban; Halil Goksel Guzel; Cihan Erol; Musa Baris Aykan; Bahadir Koylu; Omer Burak Ekinci; Ilknur Deliktas Onur; Ali Kalem; Oguz Altunok; Mustafa Seyyar; Bunyamin Guney; Orhun Akdogan; Rashad Ismayilov; Fadime Sinem Ardic; Melike Yazici; Nargiz Majidova; Sema Turker; Ece Esin; Devrim Cabuk; Hatime Arzu Yasar; Arzu Oguz; Ozan Yazici; Riza Umar Gursu; Mesut Yılmaz; Havva Yesil Cinkir; Ozturk Ates; Emir Celik; Nuri Karadurmus; Umut Demirci; Banu Ozturk; Nil Molinas Mandel; Ibrahim Vedat Bayoglu; Murat Araz; Erdem Goker; Ertugrul Bayram; Dilek Erdem; Fatih Selcukbiricik; Gul Basaran; Ahmet Sezer; Gamze Gokoz Dogu; Yasemin Kemal; Ahmet Bilici; Seyda Gunduz; Deniz Can Guven; Sercan Aksoy

PD-L1 expression in medullary thyroid carcinoma and its relevance with clinicopathological findings

ANNALS OF ONCOLOGY

IF65.4

2020-09-01

OAAI

Kemal, Y. Y.; Gun, S.; Caliskan, S.; Kefeli, M.

The value of red blood cell distribution width in endometrial cancer

CLINICAL CHEMISTRY AND LABORATORY MEDICINE

IF3.7

2015-01-01

PREAI

Kemal, Yasemin; Demirag, Guzin; Bas, Berk; Onem, Soner; Teker, Fatih; Yucel, Idris